Table 1_Modified Guilu Erxian Glue restores immune tolerance in aplastic anemia by reprogr

A 17.0 MB document uploaded by Yingkai Zhang on figshare in 2026 describes a study on Modified Guilu Erxian Glue (MGEG) for treating aplastic anemia. The research uses network pharmacology, mass cytometry (CyTOF), flow cytometry, and Western blot to investigate MGEG's immunomodulatory effects via the miR-146a/STAT1/SOCS1 axis. The dataset is licensed under CC-BY-4.0.

Use Cases

• Analyzing T cell subset reprogramming based on CyTOF and flow cytometry data mentioned in the description
• Studying the miR-146a/STAT1/SOCS1 signaling axis modulation described in the mechanistic results
• Investigating the effects of herbal formulas on immune tolerance restoration in aplastic anemia mouse models

Strengths

• The description details specific experimental methods including HPLC-ESI-MS, network pharmacology, CyTOF, and Western blot
• The study includes in vivo results from an aplastic anemia mouse model assessing peripheral blood parameters and bone marrow histopathology

Limitations

• The dataset is a 17.0 MB DOCX file, which is a small document format not structured for direct computational analysis
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment

Provenance

Source

figshare

Collection Method

Experimental study using mouse models, mass cytometry, and molecular biology techniques.

Freshness

Last updated 2026-05-29 04:49:04; freshness should be verified